Global Omics-Based Clinical Trials Market - Forecasts 2022-2028

Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional

Published	Pages	Publisher	Report code
Apr 2022	200	Bizwit Research	ASDR-599840

Published: Apr 2022 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-599840

Parexel International Corporation
Pharmaceutical Product Development (PPD)
Charles River Laboratory
ICON plc
SGS SA
Eli Lilly and Company
Pfizer Inc.
Covance Inc.
Novo Nordisk
Rebus Bio

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, CNS, Cardiology), By Region, And Segment Forecasts, 2021 - 2028

This report can be of interest as well:

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III...

Published: April, 2021 | Report code: ASDR-580036

Mark your calendar:

Oligonucleotide Therapeutics and Delivery Conference 2024

09 September - 10 September, 2024
London, United Kingdom